EXCEED: Exforge®-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: Study rationale, design, and participant characteristics

Therapeutic Advances in Cardiovascular Disease

Volumn 3, Issue 6, 2009, Pages 429-439

  Hassanein, Amira ^a   Desai, Akshay ^a   Verma, Anil ^a   Oparil, Suzanne ^a   Izzo, Joseph ^a   Rocha, Richardo ^a   Hilkert, Robert ^a   Seifu, Youdit ^a   Pitt, Bertrand ^a   Solomon, Scott ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Amlodipine; Angiotensin receptor blockers; Calcium channel blockers; Diastolic dysfunction; EXCEED; Hypertension; Valsartan

Indexed keywords

AMLODIPINE; AMLODIPINE VALSARTAN; AMLODIPINE-VALSARTAN; ANTIHYPERTENSIVE AGENT; TETRAZOLE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE PLUS VALSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DRUG COMBINATION; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; MANOMETRY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; ADULT; AGE; APPENDICITIS; ARTERIAL STIFFNESS; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; DIASTOLIC DYSFUNCTION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; HEART ATRIUM FIBRILLATION; HEART RATE; HYPOTENSION; MAJOR CLINICAL STUDY; MELANOMA; OPEN STUDY; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PANCREATITIS; PERIPHERAL EDEMA; PNEUMONIA; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLE; SYSTOLIC BLOOD PRESSURE; THYROID ADENOMA; TISSUE DOPPLER IMAGING; TONOMETRY;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIASTOLE; DRUG COMBINATIONS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MANOMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; RADIAL ARTERY; SEVERITY OF ILLNESS INDEX; TETRAZOLES;

EID: 74949084083     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944709341301     Document Type: Article

References (36)

1. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252.
2. de Champlain, J., Karas, M., Assouline, L., Le Blanc, A.R., Dubé, B. and Larochelle, P. ( 2007) Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients. J Clin Hypertens 9: 168-178.
3. Devereux, R.B., Alonso, D.R., Lutas, E.M., Gottlieb, G.J., Campo, E., Sachs, I. et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458.
4. Diez, J., Querejeta, R., Lopez, B., González, A., Larman, M., José, L. et al. (2002) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105: 2512-2517.
5. Douglas, P.S. ( 2003) The left atrium: a marker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol 42: 1206-1207.
6. Gaasch, W.H. and Zile, M.R. ( 2004) Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 55: 373-394.
7. Gavin, I.W., Avijit, L., Sophie, C.B., Collinson, P. and Senior, R. ( 2005) What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease ? Eur Heart J 26: 2269-2276.
8. Hansson, L., Hender, T. and Dahlof, B. ( 1992) Prospective Randomized Open Blinded End-point (PROBE) Study: A novel design for intervention trials. Blood Press 1: 113-119.
9. Henein, M., Lindqvist, P., Francis, D., Waldenström, A. and Kazzam, E. ( 2002) Tissue Doppler analysis of age-dependency in diastolic ventricular behavior and filling: a cross-sectional study of healthy hearts (the Umea General Population Heart Study). Eur Heart J 23: 162-171.
10. Isnard, R.N., Pannier, B.M., Laurent, S., London, G.M., Diebold, B. and Safar, M.E. ( 1989) Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a non-invasive study. J Am Coll Cardiol 13: 399-405.
11. Izzo, J.L. ( 2005) Your drug, my drug, or our drugs How aggressive should we be with antihypertensive therapy? J Clin Hypertens 7: 5-7.
12. Jacque, D.C., Pinsky, M., Severyn, D. and Gorcsan, J. ( 2004) Influence of alterations in loading on mitral annular velocity by tissue Doppler echocardiography and its associated ability to predict filling pressures. Chest 126: 1910-1918.
13. Klingbeil, A.U., Schneider, M., Martus, P., Messerli, F.H. and Schmieder, R.E. ( 2003) A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 115: 41-46.
14. Kohno, F., Kumada, T., Kambayashi, M., Hayashida, W., Ishikawa, N. and Sasayama, S. ( 1996) Change in aortic end-systolic pressure by alterations in loading sequence and its relation to left ventricular isovolumic relaxation. Circulation 93: 2080-2087.
15. Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Patricia, A. et al. (2005) Recommendations for Chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463.
16. Lewington, S., Clarke, R., Qizilbash, N., Peto, R. and Collins, R. ( 2002) Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet 360: 1903-1913.
17. Lu, H.K., Fern, R.J., Luthin, D., Linden, J., Liu, L.P., Cohen, C.J. et al. (1996) Angiotensin II stimulates T-type calcium channel current via activation of a G protein. Am J Physiol 271: C1340-C1349.
18. Manning, W.J., Shannon, R.P., Santinga, J.A., Parker, J.A., Gervino, E.V., Come, P.C. et al. (1991) Reversal of changes in left ventricular diastolic filling associated with normal aging using diltiazem. Am J Cardiol 67: 894-896.
19. Marks, A.R. ( 2000) Cardiac intracellular calcium release channels: role in heart failure. Circ Res 87: 8-11.
20. Morgan, J.P. ( 1991) Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325: 625-632.
21. Ohno, Y., Kanno, Y., Mauruyama, T., Morii, T., Eguchi, T., Hirao, K. et al. (2008) Attenuated radial augmentation index is associated with successful long term antihypertensive treatment. J Human Hypertens 22: 144-146.
22. O'Rourke, M., Nichols, W.W., O'Brien, E., Kingwell, B.A. and Blombery, P.A. ( 2005) Effects of ramipril on arterial stiffness. Hypertension 46: e14.
23. Philip, T., Smith, T.R., Glazer, R., Wernsing, M., Yen, J., Jin, J. et al. (2007) Two multicenter, 8 weeks, randomized, double blind, placebo-controlled, parallel group studies evaluating the efficacy and tolerability of Amlodipine and Valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Therapeut 29: 563-580.
24. Pritchette, A.M., Jacobson, S.T., Mahoney, D.W., Rodeheffer, R.J., Bailey, K.R. and Redfield, M.M. ( 2003) Left atrial volume as an index of left atrial size. A population based study. J Am Coll Cardiol 41: 1036-1043.
25. Setaro, J.F., Zaret, B.L., Schulman, D.S., Black, H.R. and Soufer, R. ( 1990) Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 66: 981-986.
26. Slama, M., Susic, D., Varagic, J. and Frohlich, E. ( 2002) Diastolic dysfunction in hypertension. Curr Opin Cardiol 17: 368-373.
27. Solomon, S.D., Janardhanan, R., Verma, A., Bourgoun, M., Daley, W.L., Purkayastha, D. et al. (2007) Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic dysfunction in patients with hypertension and diastolic dysfunction: a randomized trial. Lancet 369: 2079-2087.
28. Takami, T. and Shigematsu, M. ( 2003) Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension. Clin Experiment Hypertens 25: 525-535.
29. Tsang, T.S., Barnes, M.E. and Gersh, B.J. ( 2003) Prediction of risk for first age-related cardiovascular events in an elderly population. J Am Coll Cardiol 42: 1199-1205.
30. Vasan, R.S. and Levy, D. ( 1996) The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Arch Intern Med 156: 1789-1796.
31. Vasan, R.S., Larson, M.G., Leip, E.P., Kannel, W.B. and Levy, D. ( 2001) Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 358: 1682-1686.
32. Vasan, R.S., Larson, M.G., Leip, E.P., Evans, J.C., O'Donnell, C.J., Kannel, W.B. et al. (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345: 1291-1297.
33. Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Pede, S. and Porcella, C. ( 1998) Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 32: 983-988.
34. Wachtell, K., Bella, J.N., Rokkedal, J., Vittorio Palmieri, V., Papademetriou, V., Dahlöf, B. et al. (2002) Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation 105: 1071-1076.
35. World Health Report (2002) Reducing risks, promoting healthy life. World Health Organization : Geneva, Switzerland, Available at: http://www.who.int/whr/ 2002
36. Zile, M. and Brutsaert, D. ( 2002) New concepts in diastolic dysfunction and diastolic heart failure: I. Diagnosis, prognosis, and measurements of diastolic function. Circulation 105: 1387.